Invivyd (IVVD) Change in Acquisitions & Divestments (2021 - 2023)
Invivyd posted quarterly Change in Acquisitions & Divestments of $77.9 million for Q4 2023, up 289.59% year-on-year from $20.0 million in Q4 2022, and down 18.1% on a QoQ basis from $95.1 million in Q3 2023.
Invivyd (IVVD) has 3 years of Change in Acquisitions & Divestments data on file, last reported at $77.9 million in Q4 2023.
- For the quarter ending Q4 2023, Change in Acquisitions & Divestments rose 289.59% year-over-year to $77.9 million; the trailing twelve-month figure through Sep 2024 stood at $77.9 million (down 75.23% YoY), and the FY2023 full-year result was $372.5 million, up 439.86% from the prior year.
- Change in Acquisitions & Divestments for Q4 2023 stood at $77.9 million, down from $95.1 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $138.0 million in Q4 2021 and bottomed at $20.0 million in Q4 2022.
- The 3-year median for Change in Acquisitions & Divestments is $77.9 million (2023), against an average of $82.8 million.
- The widest annual swing landed in 2022, when Change in Acquisitions & Divestments sank 85.51%; it then surged 289.59% in 2023.
- A 3-year view of Change in Acquisitions & Divestments shows it stood at $138.0 million in 2021, then tumbled by 85.51% to $20.0 million in 2022, then soared by 289.59% to $77.9 million in 2023.
- The last three Change in Acquisitions & Divestments figures came in at $77.9 million (Q4 2023), $95.1 million (Q3 2023), and $123.8 million (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Invivyd | 208.38 Mn | -18.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 77.92 Mn |
| Dec 31, 2023 | 77.92 Mn |
| Sep 30, 2023 | 95.14 Mn |
| Sep 30, 2023 | 95.14 Mn |
| Jun 30, 2023 | 123.79 Mn |
| Jun 30, 2023 | 123.79 Mn |
| Mar 31, 2023 | 75.66 Mn |
| Mar 31, 2023 | 75.66 Mn |
| Dec 31, 2022 | 20.00 Mn |
| Dec 31, 2022 | 20.00 Mn |
| Mar 31, 2022 | 49.00 Mn |
| Mar 31, 2022 | 49.00 Mn |
| Dec 31, 2021 | 138.00 Mn |
| Dec 31, 2021 | 138.00 Mn |